Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The physical barrier in the upper stomach, known as the gastric mucosal barrier, is a defense mechanism composed of a thick bicarbonate-rich mucus layer and the underlying epithelium, which is sealed by tight junctions[3][9][2]. This structure protects the stomach lining from autodigestion by gastric acid, pepsin, and pathogens, and allows for the safe digestion of food. Continuous replacement of mucosal cells and the integrity of tight junctions are key to maintaining this barrier. Ulceration and gastritis can occur when this barrier is disrupted, either by *Helicobacter pylori* infection, NSAID use, or other damaging agents[3][2][9]. In summary, “physical barrier in upper stomach” is not a specific molecule, receptor, or classic drug target, but a composite histo-anatomical structure.
Neutralization of gastric acid (antacids)[3]; Reduction of gastric acid secretion (proton pump inhibitors, H2 antagonists); Enhancement of mucus or bicarbonate production (prostaglandin analogs like misoprostol); Barrier coating of ulcers (sucralfate)
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gastric mucosal physical barrier.